If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Health Outcomes
Download FREE Excerpt
10 Info Graphics
21 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Demonstrating a drug’s value in real-world settings will maximize a pharmaceutical organization's business and clinical success. The Health Economics Outcomes Research function is a key player in generating value-oriented data, but it needs support via technology, training and staff to effectively generate and utilize health outcomes data.
This study examines the different technologies/platforms and their effectiveness in communicating outcomes information and how organizations approach the issue of training for the HEOR function. The study also highlights HEOR staffing levels as well as where this critical function sits within organizations. The last chapter includes respondents' lessons learned, success stories and pitfalls they have encountered.
Segmentation based on two areas: Geographic responsibility and Medical Affairs vs. Market Access functions
Technology and Tools
Fifty-four medical leaders from 40 top life-science companies were engaged through a benchmarking survey.
Pharmaceutical; Consumer Products; Health Care; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Manufacturing; Diagnostic; Medical Device; Communications
AbbVie; Astellas; Merck Serono; Novartis; Sanofi; Boehringer Ingelheim; Eisai; Pfizer; Merck Sharp & Dohme; Bayer; Lundbeck; CSL Behring; Ipsen; Novo Nordisk; Takeda Pharmaceuticals; Alkem; Smith & Nephew; Galderma; Seqirus; Vifor Pharma; Daiichi Sankyo; Brii Biosciences; Foundation Medicine; Seattle Genetics; La Jolla Pharmaceutical; Alexion Pharmaceuticals; Sun Pharmaceutical; Grünenthal; BioCryst Pharmaceuticals; Harmony Biosciences; BioMarin; Luminex Corporation; Dova Pharmaceuticals; Karyopharm Therapeutics; Paratek Pharmaceuticals; Pharming; Bioventus; Nucleus Global; Greenwich Biosciences; Pacira Biosciences
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.